{rfName}
A

Project information

ID: AL001-3

Fecha inicio

13-05-2020

Fecha fin

N/A


Institutional Coordinator
Institut d'Investigacions Biomèdiques August Pi i Sunyer

Financing

More information in

Analysis of institutional authors

Gonzalez Romero, YolandaMember of the research teamSanchez Del Valle Díaz, RaquelPrincipal investigator
Share
R&D Projects
>
Private project

A Phase 3, Multi-center, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of AL001 in Individuals at Risk for or With Frontotemporal Dementia Due to Heterozygous Mutations in the Progranulin Gene

Researchers: Gonzalez Romero, Yolanda (Miembro del equipo de investigación); Sanchez del Valle Díaz, Raquel (Investigador principal (IP))

Affiliations

IDIBAPS. -. Neurología (Service)
IDIBAPS. 4.02 - Isquèmia Cerebral: Estudis Clínics i Experimentals. Malalties cerebrovasculars (Group)
IDIBAPS. 4.12 - Malaltia d'Alzheimer i altres transtorns cognitius. Malaltia d'Alzheimer i altres trastorns cognitius (Group)
Neurologia, Unidad de patología vascular cerebral. HOSPITAL CLINICO Y PROVINCIAL DE BARCELONA (R & D Center)
NEUROLOGIA, Unidad De Alzheimer y otros trastornos cognitivos (UATC). HOSPITAL CLINICO Y PROVINCIAL DE BARCELONA (Dpt./cen./etc.)
Neurologia. HOSPITAL CLINICO Y PROVINCIAL DE BARCELONA (Dpt./cen./etc.)
See more

Abstract


Keywords

Financing

Quality index

Financer

Alector, LLC. ; Alector Inc

Institutional Coordinator

Si

Related items